AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
Healthcare Triangle Launches ZoraNex as Digital Mental Health Competition Heats Up
Healthcare Triangle has introduced ZoraNex, an AI-driven digital self-care therapy platform aimed at the large mental health market. The launch reflects both the commercial appeal of digital behavioral health and the difficulty of standing out in a crowded, closely scrutinized category.
AI is Becoming the New Front Door for Patient Navigation
The AMA’s coverage of an intuitive AI portal highlights how health systems are using AI to route patients to the right care setting more efficiently. The bigger story is that navigation, not diagnosis, may be one of AI’s most practical near-term roles in healthcare.
AI and Telemedicine Are Becoming Core Tools in Japan’s Healthcare Strategy
A profile of ALLM shows how AI and telemedicine are being used to strengthen Japan’s healthcare system. The story highlights a broader international trend: countries are increasingly treating digital health as infrastructure, not just innovation.
Statista Data Shows More Americans Are Turning to AI for Health Information
Statista’s new data on AI use for health information by age highlights a behavioral shift in how patients seek answers. The pattern may help explain why health systems, regulators, and consumer platforms are racing to influence AI-driven information flows.
Breast Cancer AI Is Entering the Pathology Lab — and the Real-World Questions Are Getting Harder
Medical News Today highlights the tension between AI’s promise in melanoma and the realities of clinical deployment, while Devdiscourse points to AI-driven pathology reshaping breast cancer detection and prognosis. Together, they underscore a field moving from proof-of-concept toward questions of trust, integration, and accountability.
Could AI Replace Colonoscopy? A New Stool Test Detects 90% of Colorectal Cancers
ScienceDaily reports on a stool test that detects 90% of colorectal cancers, adding fuel to the debate over noninvasive screening. The result could reshape screening behavior, but only if sensitivity, specificity, and follow-up pathways hold up outside the study setting.
AI Pathology Is Becoming the New Growth Engine in Oncology
Medscape’s look at pathology in oncology argues that AI is shifting cancer diagnostics from pixels to prescriptions. The story is less about a single breakthrough than about a broader restructuring of how cancer information is interpreted and acted on.
The Cancer Diagnostics Market Is Signaling a Shift Toward AI-Enabled, Noninvasive Screening
A new market forecast suggests the noninvasive cancer diagnostics sector could reach $165.2 billion by 2030, driven by liquid biopsy, AI-enabled screening, and multi-cancer detection tests. The number matters less than the direction: cancer detection is moving toward earlier, broader, and less invasive testing.
AI Lung Cancer Screening Moves From Promising Model to Public Health Pilot in Telangana
AstraZeneca and Telangana’s government are rolling out AI-powered lung cancer screening in public hospitals, signaling a shift from isolated demonstrations to real-world deployment. The initiative is notable not just for its technology, but for its public-sector framing: screening at scale where early detection gaps are often widest.
A New AI Model for Lung Cancer Detection Hints at Earlier Diagnosis
Medical Xpress reports on a new AI model aimed at helping doctors detect lung cancer earlier. The key question is no longer whether AI can find patterns in scans, but whether it can reliably move diagnosis earlier enough to change outcomes.
At AACR, Natera Stresses That Oncology AI Is Becoming a Platform, Not a Feature
Natera’s AACR presence, centered on 20 abstracts, highlights how diagnostic and monitoring companies are packaging AI as part of a broader oncology platform. The significance lies in the shift from standalone test claims to integrated evidence generation across the cancer journey.
Blood Tests, AI Screening, and Multi-Cancer Detection Are Turning Cancer Detection into a Market Race
Coverage from Rolling Out suggests blood-based cancer testing is moving from niche research into the mainstream conversation. As AI-powered screening expands, the key question becomes whether convenience can be matched by clinical validity and equitable access.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.